We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cervarix, Gardasil Approved for New Indications
Cervarix, Gardasil Approved for New Indications
October 23, 2009
GlaxoSmithKline’s (GSK) human papillomavirus (HPV) vaccine Cervarix has received FDA approval for use in girls and young women age 10–25, while
Merck’s Gardasil has won a new indication, extending its use to boys and men age 9–26.